Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Oxymorphone

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,413Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Impax Inks $145M Deal With Direct Purchasers In Opana MDL
    Impax Inks $145M Deal With Direct Purchasers In Opana MDL

    20 Jul 2022

    // Lauraann Wood LAW360

    https://www.law360.com/lifesciences/articles/1513329?utm_source=feedly&utm_medium=rss&utm_campaign=section

    Lauraann Wood LAW360
    20 Jul 2022
    Share Share
    Families impacted by the opioid epidemic closely watching J&J trial
    Families impacted by the opioid epidemic closely watching J&J trial

    28 May 2019

    // CBSNEWS

    https://www.cbsnews.com/news/johnson-and-johnson-families-impacted-by-opioid-epidemic-closely-watching-trial-today-2019-05-28/

    CBSNEWS
    28 May 2019
    Share Share
    FDA declines to approve Mallinckrodt's abuse-deterrent opioid painkiller
    FDA declines to approve Mallinckrodt's abuse-deterrent opioid painkiller

    13 Dec 2018

    // Tamara Mathias REUTERS

    https://www.reuters.com/article/us-mallinckrodt-fda/fda-declines-to-approve-mallinckrodts-abuse-deterrent-opioid-painkiller-idUSKBN1OB1BO?feedType=RSS&feedName=healthNews

    Tamara Mathias REUTERS
    13 Dec 2018
    Share Share
    FDA to Replace Analgesic Drug Development Guidance With New Documents
    FDA to Replace Analgesic Drug Development Guidance With New Documents

    30 Aug 2018

    // Michael Mezher RAPS

    https://www.raps.org/news-and-articles/news-articles/2018/8/fda-to-replace-analgesic-drug-development-guidance?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2030%20August

    Michael Mezher RAPS
    30 Aug 2018
    Share Share
    FDA declines to approve Pain Therapeutics' opioid drug, shares plunge
    FDA declines to approve Pain Therapeutics' opioid drug, shares plunge

    07 Aug 2018

    // Manas Mishra REUTERS

    https://www.reuters.com/article/us-pain-therapeutic-fda/fda-declines-to-approve-pain-therapeutics-abuse-deterrent-opioid-drug-idUSKBN1KR195

    Manas Mishra REUTERS
    07 Aug 2018
    Share Share
    Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis
    Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis

    01 Mar 2018

    // E. Sagonowsky FIERCE PHARMA

    https://www.fiercepharma.com/legal/mallinckrodt-probed-over-oxymorphone-generics-growing-opioid-crisis

    E. Sagonowsky FIERCE PHARMA
    01 Mar 2018
    Share Share